Combination Therapies for Smoking Cessation: A Hierarchical Bayesian Meta-Analysis

American Journal of Preventive Medicine

Volumn 51, Issue 6, 2016, Pages 1060-1071

  Windle, Sarah B ^a   Filion, Kristian B ^a,b   Mancini, Joseph G ^a   Adye White, Lauren ^a   Joseph, Lawrence ^b,c   Gore, Genevieve C ^b   Habib, Bettina ^a   Grad, Roland ^b,d   Pilote, Louise ^b,c   Eisenberg, Mark J ^a,b,d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE PATCH; VARENICLINE;

BAYES THEOREM; BEHAVIOR THERAPY; COMBINATION DRUG THERAPY; COMPARATIVE EFFECTIVENESS; HUMAN; META ANALYSIS; MONOTHERAPY; NICOTINE REPLACEMENT THERAPY; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING CESSATION; SYSTEMATIC REVIEW; DRUG THERAPY; MULTIMODALITY CANCER THERAPY; SMOKING;

BAYES THEOREM; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; HUMANS; SMOKING; SMOKING CESSATION;

EID: 84994853656     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2016.07.011     Document Type: Review

References (143)

1. 1 Fiore, M., Tobacco Use and Dependence Guideline Panel. Treating Tobacco Use and Dependence: 2008 Update. 2008, DHHS, Public Health Service, Rockville, MD: U.S.
2. 2 Meschia, J.F., Bushnell, C., Boden-Albala, B., et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45:12 (2014), 3754–3832, 10.1161/STR.0000000000000046.
3. 3 Pfizer Canada Inc. Champix product monograph. www.pfizer.ca/en/our_products/products/monograph/152. Published 2014. Accessed February 9, 2015.
4. 4 GlaxoSmithKline. Zyban prescribing information. www.gsksource.com/gskprm/htdocs/documents/ZYBAN-PI-MG.PDF. Published 2014. Accessed February 9, 2015.
5. 5 Pfizer. Nicotrol inhaler prescribing information. www.pfizer.com/files/products/uspi_nicotrol_inhaler.pdf. Published 2008. Accessed February 9, 2015.
6. 6 Pfizer. Nicotrol nasal spray prescribing information. www.pfizer.com/files/products/uspi_nicotrol.pdf. Published 2010. Accessed February 9, 2015.
7. 7 Stead, L.F., Lancaster, T., Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev, 12, 2012, CD009670, 10.1002/14651858.cd009670.pub2.
8. 8 Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:5 (2009), 336–341, 10.1016/j.ijsu.2010.02.007.
9. 9 U.S. National Library of Medicine. PubMed subject filters: search strategy used to create the systematic reviews subset on PubMed. www.nlm.nih.gov/bsd/pubmed_subsets/sysreviews_strategy.html. Accessed April 12, 2013.
10. 10 Cochrane Central Register of Controlled Trials. www.cochrane.org/editorial-and-publishing-policy-resource/cochrane-central-register-controlled-trials-central. Published 2014. Accessed April 16, 2014.
11. 11 Eady, A.M., Wilczynski, N.L., Haynes, R.B., PsycINFO search strategies identified methodologically sound therapy studies and review articles for use by clinicians and researchers. J Clin Epidemiol 61:1 (2008), 34–40, 10.1016/j.jclinepi.2006.09.016.
12. 12 Higgins J, Green S, eds., The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: Wiley-Blackwell; 2008. http://dx.doi.org/10.1002/9780470712184.
13. 13 Albrecht, S.A., Caruthers, D., Patrick, T., et al. A randomized controlled trial of a smoking cessation intervention for pregnant adolescents. Nurs Res 55:6 (2006), 402–410, 10.1097/00006199-200611000-00004.
14. 14 Alterman, A.I., Gariti, P., Mulvaney, F., Short- and long-term smoking cessation for three levels of intensity of behavioral treatment. Psychol Addict Behav 15:3 (2001), 261–264, 10.1037/0893-164X.15.3.261.
15. 15 Anthenelli, R.M., Morris, C., Ramey, T.S., et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med 159:6 (2013), 390–400, 10.7326/0003-4819-159-6-201309170-00005.
16. 16 Aubin, H.J., Bobak, A., Britton, J.R., et al. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax 63:8 (2008), 717–724, 10.1136/thx.2007.090647.
17. 17 Baker, A.L., Richmond, R., Kay-Lambkin, F.J., et al. Randomized controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders. Nicotine Tob Res 17:8 (2015), 946–954, 10.1093/ntr/ntv039.
18. 18 Bakkevig, O., Steine, S., von Hafenbradl, K., Laerum, E., Smoking cessation. A comparative, randomised study between management in general practice and the behavioural programme SmokEnders. Scand J Prim Health Care 18:4 (2000), 247–251, 10.1080/028134300448832.
19. 19 Blondal, T., Controlled trial of nicotine polacrilex gum with supportive measures. Arch Intern Med 149:8 (1989), 1818–1821, 10.1001/archinte.1989.00390080080018.
20. 20 Blondal, T., Franzon, M., Westin, A., A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. Eur Respir J 10:7 (1997), 1585–1590, 10.1183/09031936.97.10071585.
21. 21 Blondal, T., Gudmundsson, L.J., Olafsdottir, I., Gustavsson, G., Westin, A., Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ 318:7179 (1999), 285–288, 10.1136/bmj.318.7179.285.
22. 22 Bohadana, A., Nilsson, F., Rasmussen, T., Martinet, Y., Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 160:20 (2000), 3128–3134, 10.1001/archinte.160.20.3128.
23. 23 Brown, R.A., Niaura, R., Lloyd-Richardson, E.E., et al. Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine Tob Res 9:7 (2007), 721–730, 10.1080/14622200701416955.
24. 24 Caldwell, B.O., Adamson, S.J., Crane, J., Combination rapid-acting nicotine mouth spray and nicotine patch therapy in smoking cessation. Nicotine Tob Res 16:10 (2014), 1356–1364.
25. 25 Campbell, I.A., Lyons, E., Prescott, R.J., Stopping smoking. Do nicotine chewing-gum and postal encouragement add to doctors’ advice. Practitioner 231:1423 (1987), 114–117.
26. 26 Campbell, I.A., Prescott, R.J., Tjeder-Burton, S.M., Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum. Respir Med 85:2 (1991), 155–157, 10.1016/S0954-6111(06)80295-7.
27. 27 Campbell, I.A., Prescott, R.J., Tjeder-Burton, S.M., Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. Respir Med 90:1 (1996), 47–51, 10.1016/S0954-6111(96)90244-9.
28. 28 Christenhusz, L., Pieterse, M., Seydel, E., van der Palen, J., Prospective determinants of smoking cessation in COPD patients within a high intensity or a brief counseling intervention. Patient Educ Couns 66:2 (2007), 162–166, 10.1016/j.pec.2006.11.006.
29. 29 Cinciripini, P.M., Cinciripini, L.G., Wallfisch, A., Haque, W., Van Vunakis, H., Behavior therapy and the transdermal nicotine patch: effects on cessation outcome, affect, and coping. J Consult Clin Psychol 64:2 (1996), 314–323, 10.1037/0022-006X.64.2.314.
30. 30 Cooney, N.L., Cooney, J.L., Perry, B.L., et al. Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum. Addiction 104:9 (2009), 1588–1596, 10.1111/j.1360-0443.2009.02624.x.
31. 31 Cooper, T.V., Klesges, R.C., Debon, M.W., Zbikowski, S.M., Johnson, K.C., Clemens, L.H., A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women. Addict Behav 30:1 (2005), 61–75, 10.1016/j.addbeh.2004.04.013.
32. 32 Crofton, J., Campbell, I.A., Cole, P.V., Comparison of four methods of smoking withdrawal in patients with smoking related diseases. Br Med J 286:6365 (1983), 595–597, 10.1136/bmj.286.6365.595.
33. 33 Cropsey, K.L., Clark, C.B., Zhang, X.N., Hendricks, P.S., Jardin, B.F., Lahti, A.C., Race and medication adherence moderate cessation outcomes in criminal justice smokers. Am J Prev Med 49:3 (2015), 335–344, 10.1016/j.amepre.2015.03.014.
34. 34 Curry, S.J., Ludman, E.J., Graham, E., Stout, J., Grothaus, L., Lozano, P., Pediatric-based smoking cessation intervention for low-income women: a randomized trial. Arch Pediatr Adolesc Med 157:3 (2003), 295–302, 10.1001/archpedi.157.3.295.
35. 35 Curry, S.J., Marlatt, G.A., Gordon, J., Baer, J.S., A comparison of alternative theoretical approaches to smoking cessation and relapse. Health Psychol 7:6 (1988), 545–556, 10.1037/0278-6133.7.6.545.
36. 36 Daughton, D., Susman, J., Sitorius, M., et al. Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group. Arch Fam Med 7:5 (1998), 425–430, 10.1001/archfami.7.5.425.
37. 37 Ebbert, J.O., Hatsukami, D.K., Croghan, I.T., et al. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA 311:2 (2014), 155–163, 10.1001/jama.2013.283185.
38. 38 Eisenberg, M.J., Grandi, S.M., Gervais, A., et al. Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial. J Am Coll Cardiol 61:5 (2013), 524–532, 10.1016/j.jacc.2012.08.1030.
39. 39 Evins, A.E., Cather, C., Culhane, M.A., et al. A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol 27:4 (2007), 380–386, 10.1097/01.jcp.0b013e3180ca86fa.
40. 40 Feeney, G.F.X., McPherson, A., Connor, J.P., McAlister, A., Young, R.M., Garrahy, P., Randomized controlled trial of two cigarette quit programmes in coronary care patients after acute myocardial infarction. Intern Med J 31:8 (2001), 470–475, 10.1046/j.1445-5994.2001.00110.x.
41. 41 Fiore, M.C., McCarthy, D.E., Jackson, T.C., et al. Integrating smoking cessation treatment into primary care: an effectiveness study. Prev Med 38:4 (2004), 412–420, 10.1016/j.ypmed.2003.11.002.
42. 42 Fossati, R., Apolone, G., Negri, E., et al. A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care. Arch Intern Med 167:16 (2007), 1791–1797, 10.1001/archinte.167.16.1791.
43. 43 Fowler, G., Randomised trial of nicotine patches in general practice: results at one year. Br Med J 308:6942 (1994), 1476–1477, 10.1136/bmj.308.6942.1476.
44. 44 Garcia, M.P., Becona, E., Evaluation of the amount of therapist contact in a smoking cessation program. Span J Psychol 3:1 (2000), 28–36, 10.1017/S1138741600005515.
45. 45 Garvey, A.J., Kinnunen, T., Nordstrom, B.L., et al. Effects of nicotine gum dose by level of nicotine dependence. Nicotine Tob Res 2:1 (2000), 53–63, 10.1080/14622200050011303.
46. 46 Gifford, E.V., Kohlenberg, B.S., Hayes, S.C., et al. Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes? A randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation. Behav Ther 42:4 (2011), 700–715, 10.1016/j.beth.2011.03.002.
47. 47 Gilbert, J.R., Wilson, D.M., Best, J.A., et al. Smoking cessation in primary care. A randomized controlled trial of nicotine-bearing chewing gum. J Fam Pract 28:1 (1989), 49–55.
48. 48 Ginsberg, D., Hall, S.M., Rosinski, M., Partner support, psychological treatment, and nicotine gum in smoking treatment: an incremental study. Int J Addict 27:5 (1992), 503–514, 10.3109/10826089209063465.
49. 49 Glavas, D., Rumboldt, M., Rumboldt, Z., Smoking cessation with nicotine replacement therapy among health care workers: randomized double-blind study. Croat Med J 44:2 (2003), 219–224.
50. 50 Glover, E.D., Glover, P.N., Franzon, M., et al. A comparison of a nicotine sublingual tablet and placebo for smoking cessation. Nicotine Tob Res 4:4 (2002), 441–450, 10.1080/1462220021000018443.
51. 51 Gonzales, D., Hajek, P., Pliamm, L., et al. Re-treatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial. Clin Pharmacol Ther 96:3 (2014), 390–396, 10.1038/clpt.2014.124.
52. 52 Gonzales, D., Rennard, S.I., Nides, M., et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 296:1 (2006), 47–55, 10.1001/jama.296.1.47.
53. 53 Gritz, E.R., Danysh, H.E., Fletcher, F.E., et al. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clin Infect Dis 57:4 (2013), 608–615, 10.1093/cid/cit349.
54. 54 Hall, S.M., Humfleet, G.L., Munoz, R.F., Reus, V.I., Robbins, J.A., Prochaska, J.J., Extended treatment of older cigarette smokers. Addiction 104:6 (2009), 1043–1052, 10.1111/j.1360-0443.2009.02548.x.
55. 55 Hall, S.M., Humfleet, G.L., Reus, V.I., Munoz, R.F., Hartz, D.T., Maude-Griffin, R., Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry 59:10 (2002), 930–936, 10.1001/archpsyc.59.10.930.
56. 56 Hall, S.M., Tunstall, C.D., Ginsberg, D., Benowitz, N.L., Jones, R.T., Nicotine gum and behavioral treatment: a placebo controlled trial. J Consult Clin Psychol 55:4 (1987), 603–605, 10.1037/0022-006X.55.4.603.
57. 57 Hennrikus, D.J., Lando, H.A., McCarty, M.C., et al. The TEAM project: the effectiveness of smoking cessation intervention with hospital patients. Prev Med 40:3 (2005), 249–258, 10.1016/j.ypmed.2004.05.030.
58. 58 Herrera, N., Franco, R., Herrera, L., Partidas, A., Rolando, R., Fagerstrom, K.O., Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest 108:2 (1995), 447–451, 10.1378/chest.108.2.447.
59. 59 Heydari, G., Talischi, F., Tafti, S.F., Masjedi, M.R., Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran. Int J Tuberc Lung Dis 16:2 (2012), 268–272, 10.5588/ijtld.11.0183.
60. 60 Hill, R.D., Rigdon, M., Johnson, S., Behavioral smoking cessation treatment for older chronic smokers. Behav Ther 24:2 (1993), 321–329, 10.1016/S0005-7894(05)80272-2.
61. 61 Hjalmarson, A., Franzon, M., Westin, A., Wiklund, O., Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. Arch Intern Med 154:22 (1994), 2567–2572, 10.1001/archinte.1994.00420220059007.
62. 62 Hjalmarson, A., Nilsson, F., Sjostrom, L., Wiklund, O., The nicotine inhaler in smoking cessation. Arch Intern Med 157:15 (1997), 1721–1728, 10.1001/archinte.1997.00440360143016.
63. 63 Holt, S., Timu-Parata, C., Ryder-Lewis, S., Weatherall, M., Beasley, R., Efficacy of bupropion in the indigenous Maori population in New Zealand. Thorax 60:2 (2005), 120–123, 10.1136/thx.2004.030239.
64. 64 Hughes, J.R., Gust, S.W., Keenan, R.M., Fenwick, J.W., Healey, M.L., Nicotine vs placebo gum in general medical practice. JAMA 261:9 (1989), 1300–1305, 10.1001/jama.1989.03420090064032.
65. 65 Hughes, J.R., Lesmes, G.R., Hatsukami, D.K., et al. Are higher doses of nicotine replacement more effective for smoking cessation?. Nicotine Tob Res 1:2 (1999), 169–174, 10.1080/14622299050011281.
66. 66 Hurt, R.D., Dale, L.C., Fredrickson, P.A., et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA 271:8 (1994), 595–600, 10.1001/jama.1994.03510320035026.
67. 67 Hurt, R.D., Sachs, D.P., Glover, E.D., et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:17 (1997), 1195–1202, 10.1056/NEJM199710233371703.
68. 68 Jensen, E.J., Schmidt, E., Pedersen, B., Dahl, R., Effect of nicotine, silver acetate, and ordinary chewing gum in combination with group counselling on smoking cessation. Thorax 45:11 (1990), 831–834, 10.1136/thx.45.11.831.
69. 69 Jorenby, D.E., Hays, J., Rigotti, N.A., et al. Efficacy of varenicline, an 42 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296:1 (2006), 56–63, 10.1001/jama.296.1.56.
70. 70 Jorenby, D.E., Leischow, S.J., Nides, M.A., et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:9 (1999), 685–691, 10.1056/NEJM199903043400903.
71. 71 Killen, J.D., Fortmann, S.P., Davis, L., Varady, A., Nicotine patch and self-help video for cigarette smoking cessation. J Consult Clin Psychol 65:4 (1997), 663–672, 10.1037/0022-006X.65.4.663.
72. 72 Killen, J.D., Fortmann, S.P., Newman, B., Varady, A., Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol 58:1 (1990), 85–92, 10.1037/0022-006X.58.1.85.
73. 73 Kornitzer, M., Boutsen, M., Dramaix, M., Thijs, J., Gustavsson, G., Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 24:1 (1995), 41–47, 10.1006/pmed.1995.1006.
74. 74 Leischow, S.J., Nilsson, F., Franzon, M., Hill, A., Otte, P., Merikle, E.P., Efficacy of the nicotine inhaler as an adjunct to smoking cessation. Am J Health Behav 20 (1996), 364–371.
75. 75 Lerman, C., Schnoll, R.A., Hawk, L.W. Jr., et al. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. Lancet Respir Med 3:2 (2015), 131–138, 10.1016/S2213-2600(14)70294-2.
76. 76 Levine, M.D., Perkins, K.A., Kalarchian, M.A., et al. Bupropion and cognitive behavioral therapy for weight-concerned women smokers. Arch Intern Med 170:6 (2010), 543–550, 10.1001/archinternmed.2010.33.
77. 77 Marley, J.V., Atkinson, D., Kitaura, T., et al. The Be Our Ally Beat Smoking (BOABS) study, a randomised controlled trial of an intensive smoking cessation intervention in a remote aboriginal Australian health care setting. BMC Public Health, 14, 2014, 32, 10.1186/1471-2458-14-32.
78. 78 Martin, J.E., Calfas, K.J., Patten, C.A., et al. Prospective evaluation of three smoking interventions in 205 recovering alcoholics: one-year results of Project SCRAP-Tobacco. J Consult Clin Psychol 65:1 (1997), 190–194, 10.1037/0022-006X.65.1.190.
79. 79 McCarthy, D.E., Piasecki, T.M., Lawrence, D.L., et al. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. Nicotine Tob Res 10:4 (2008), 717–729, 10.1080/14622200801968343.
80. 80 McDowell, I., Mothersill, K., Rosser, W., Hartman, R., A randomized trial of three approaches to smoking cessation. Can Fam Physician 31 (1985), 845–851.
81. 81 Miguez, M.C., Vazquez, F.L., Becona, E., Effectiveness of telephone contact as an adjunct to a self-help program for smoking cessation: a randomized controlled trial in Spanish smokers. Addict Behav 27:1 (2002), 139–144, 10.1016/S0306-4603(00)00166-0.
82. 82 Nakamura, M., Oshima, A., Fujimoto, Y., Maruyama, N., Ishibashi, T., Reeves, K.R., Efficacy and tolerability of varenicline, an 42 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther 29:6 (2007), 1040–1056, 10.1016/j.clinthera.2007.06.012.
83. 83 Niaura, R., Abrams, D.B., Shadel, W.G., Rohsenow, D.J., Monti, P.M., Sirota, A.D., Cue exposure treatment for smoking relapse prevention: a controlled clinical trial. Addiction 94:5 (1999), 685–695, 10.1046/j.1360-0443.1999.9456856.x.
84. 84 Niaura, R., Goldstein, M.G., Abrams, D.B., Matching high- and low-dependence smokers to self-help treatment with or without nicotine replacement. Prev Med 23:1 (1994), 70–77, 10.1006/pmed.1994.1010.
85. 85 Niaura, R., Hays, J.T., Jorenby, D.E., et al. The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial. Curr Med Res Opin 24:7 (2008), 1931–1941, 10.1185/03007990802177523.
86. 86 Nides, M., Oncken, C., Gonzales, D., et al. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch Intern Med 166:15 (2006), 1561–1568, 10.1001/archinte.166.15.1561.
87. 87 Oncken, C., Gonzales, D., Nides, M., et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med 166:15 (2006), 1571–1577, 10.1001/archinte.166.15.1571.
88. 88 Park, A.H., Lee, S.J., Oh, S.J., The effects of a smoking cessation programme on health-promoting lifestyles and smoking cessation in smokers who had undergone percutaneous coronary intervention. Int J Nurs Pract 21:2 (2015), 107–117, 10.1111/ijn.12230.
89. 89 Perng, R.P., Hsieh, W.C., Chen, Y.M., Lu, C.C., Chiang, S.J., Randomized, double blind, placebo-controlled study of transdermal. Nicotine patch for smoking cessation. J Formos Med Assoc 97:8 (1998), 547–551.
90. 90 Piper, M.E., Federman, E.B., McCarthy, D.E., et al. Efficacy of bupropion alone and in combination with nicotine gum. Nicotine Tob Res 9:9 (2007), 947–954, 10.1080/14622200701540820.
91. 91 Pirie, P.L., McBride, C.M., Hellerstedt, W., et al. Smoking cessation in women concerned about weight. Am J Public Health 82:9 (1992), 1238–1243, 10.2105/AJPH.82.9.1238.
92. 92 Pisinger, C., Glumer, C., Toft, U., et al. High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. Prev Med 46:6 (2008), 579–584, 10.1016/j.ypmed.2008.02.026.
93. 93 Pollak, K.I., Lyna, P., Bilheimer, A.K., et al. Efficacy of a couple-based randomized controlled trial to help Latino fathers quit smoking during pregnancy and postpartum: the Parejas trial. Cancer Epidemiol Biomarkers Prev 24:2 (2015), 379–385, 10.1158/1055-9965.EPI-14-0841.
94. 94 Prapavessis, H., Cameron, L., Baldi, J.C., et al. The effects of exercise and nicotine replacement therapy on smoking rates in women. Addict Behav 32:7 (2007), 1416–1432, 10.1016/j.addbeh.2006.10.005.
95. 95 Puska, P., Korhonen, H.J., Vartiainen, E., Urjanheimo, E.L., Gustavsson, G., Westin, A., Combined use of nicotine patch and gum compared with gum alone in smoking cessation: a clinical trial in North Karelia. Tob Control 4 (1995), 231–235, 10.1136/tc.4.3.231.
96. 96 Reid, R.D., Pipe, A., Dafoe, W.A., Is telephone counselling a useful addition to physician advice and nicotine replacement therapy in helping patients to stop smoking? A randomized controlled trial. CMAJ 160:11 (1999), 1577–1581.
97. 97 Richmond, R.L., Kehoe, L., de Almeida Neto, A.C., Effectiveness of a 24-hour transdermal nicotine patch in conjunction with a cognitive behavioural programme: one year outcome. Addiction 92:1 (1997), 27–31.
98. 98 Rigotti, N.A., Pipe, A.L., Benowitz, N.L., Arteaga, C., Garza, D., Tonstad, S., Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation 121:2 (2010), 221–229, 10.1161/CIRCULATIONAHA.109.869008.
99. 99 Rigotti, N.A., Thorndike, A.N., Regan, S., et al. Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med 119:12 (2006), 1080–1087, 10.1016/j.amjmed.2006.04.024.
100. 100 Robinson, L.A., Vander Weg, M.W., Riedel, B.W., Klesges, R.C., McLain-Allen, B., “Start to stop”: results of a randomised controlled trial of a smoking cessation programme for teens. Tob Control 12:suppl 4 (2003), 26–33, 10.1136/tc.12.suppl_4.iv26.
101. 101 Rovina, N., Nikoloutsou, I., Katsani, G., et al. Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice. Ther Adv Respir Dis 3:6 (2009), 279–287, 10.1177/1753465809350653.
102. 102 Russell, M.A., Stapleton, J.A., Feyerabend, C., et al. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ 306:6888 (1993), 1308–1312, 10.1136/bmj.306.6888.1308.
103. 103 Sachs, D.P., Sawe, U., Leischow, S.J., Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 153:16 (1993), 1881–1890, 10.1001/archinte.1993.00410160041003.
104. 104 Scherphof, C.S., Eijnden, R., Engels, R., Vollebergh, W.A.M., Long-term efficacy of nicotine replacement therapy for smoking cessation in adolescents: a randomized controlled trial. Drug Alcohol Depend 140 (2014), 217–220, 10.1016/j.drugalcdep.2014.04.007.
105. 105 Schneider, N.G., Jarvik, M.E., Forsythe, A.B., Read, L.L., Elliott, M.L., Schweiger, A., Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial. Addict Behav 8:3 (1983), 253–261, 10.1016/0306-4603(83)90020-5.
106. 106 Schneider, N.G., Olmstead, R., Mody, F.V., et al. Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction 90:12 (1995), 1671–1682, 10.1111/j.1360-0443.1995.tb02837.x.
107. 107 Schneider, N.G., Olmstead, R., Nilsson, F., Mody, F.V., Franzon, M., Doan, K., Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction 91:9 (1996), 1293–1306, 10.1111/j.1360-0443.1996.tb03616.x.
108. 108 Schuck, K., Bricker, J.B., Otten, R., Kleinjan, M., Brandon, T.H., Engels, R.C., Effectiveness of proactive quitline counselling for smoking parents recruited through primary schools: results of a randomized controlled trial. Addiction 109:5 (2014), 830–841, 10.1111/add.12485.
109. 109 Segnan, N., Ponti, A., Battista, R.N., et al. A randomized trial of smoking cessation interventions in general practice in Italy. Cancer Causes Control 2:4 (1991), 239–246, 10.1007/BF00052140.
110. 110 Shiffman, S., Dresler, C.M., Hajek, P., Gilburt, S.J., Targett, D.A., Strahs, K.R., Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 162:11 (2002), 1267–1276, 10.1001/archinte.162.11.1267.
111. 111 Shoptaw, S., Rotheram-Fuller, E., Yang, X., et al. Smoking cessation in methadone maintenance. Addiction 97:10 (2002), 1317–1328, 10.1046/j.1360-0443.2002.00221.x discussion 1325.
112. 112 Simon, J.A., Carmody, T.P., Hudes, E.S., Snyder, E., Murray, J., Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial. Am J Med 114:7 (2003), 555–562, 10.1016/S0002-9343(03)00081-0.
113. 113 Simon, J.A., Duncan, C., Carmody, T.P., Hudes, E.S., Bupropion for smoking cessation: a randomized trial. Arch Intern Med 164:16 (2004), 1797–1803, 10.1001/archinte.164.16.1797.
114. 114 Slama, K., Redman, S., Perkins, J., Reid, A.L., Sanson-Fisher, R.W., The effectiveness of two smoking cessation programmes for use in general practice: a randomised clinical trial. BMJ 300:6741 (1990), 1707–1709, 10.1136/bmj.300.6741.1707.
115. 115 Smith, P.M., Corso, L., Brown, K.S., Cameron, R., Nurse case-managed tobacco cessation interventions for general hospital patients: results of a randomized clinical trial. Can J Nurs Res 43:1 (2011), 98–117.
116. 116 Smith, S.S., Jorenby, D.E., Fiore, M.C., et al. Strike while the iron is hot: can stepped-care treatments resurrect relapsing smokers?. J Consult Clin Psychol 69:3 (2001), 429–439, 10.1037/0022-006X.69.3.429.
117. 117 Sutherland, G., Stapleton, J.A., Russell, M.A., et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 340:8815 (1992), 324–329, 10.1016/0140-6736(92)91403-U.
118. 118 Tashkin, D.P., Rennard, S., Hays, J.T., Ma, W., Lawrence, D., Lee, T.C., Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest 139:3 (2011), 591–599, 10.1378/chest.10-0865.
119. 119 Tonnesen, P., Lauri, H., Perfekt, R., Mann, K., Batra, A., Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial. Eur Respir J 40:3 (2012), 548–554, 10.1183/09031936.00155811.
120. 120 Tonnesen, P., Mikkelsen, K., Bremann, L., Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest 130:2 (2006), 334–342, 10.1378/chest.130.2.334.
121. 121 Tonnesen, P., Mikkelsen, K.L., Smoking cessation with four nicotine replacement regimes in a lung clinic. Eur Respir J 16:4 (2000), 717–722, 10.1034/j.1399-3003.2000.16d25.x.
122. 122 Tonnesen, P., Norregaard, J., Mikkelsen, K., Jorgensen, S., Nilsson, F., A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 269:10 (1993), 1268–1271, 10.1001/jama.1993.03500100066029.
123. 123 Tonnesen, P., Norregaard, J., Simonsen, K., Sawe, U., A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 325:5 (1991), 311–315, 10.1056/NEJM199108013250503.
124. 124 Tonnesen, P., Paoletti, P., Gustavsson, G., et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J 13:2 (1999), 238–246, 10.1034/j.1399-3003.1999.13b04.x.
125. 125 Tonnesen, P., Tonstad, S., Hjalmarson, A., et al. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med 254:2 (2003), 184–192, 10.1046/j.1365-2796.2003.01185.x.
126. 126 Tonstad, S., Farsang, C., Klaene, G., et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur Heart J 24:10 (2003), 946–955, 10.1016/S0195-668X(03)00003-4.
127. 127 Van Schayck, C.P., Kaper, J., Wagena, E.J., Wouters, E.F., Severens, J.L., The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients. Addiction 104:12 (2009), 2110–2117, 10.1111/j.1360-0443.2009.02723.x.
128. 128 Vial, R.J., Jones, T.E., Ruffin, R.E., Gilbert, A.L., Smoking cessation program using nicotine patches linking hospital to the community. J Pharm Pract Res 32:1 (2002), 57–62, 10.1002/jppr200232157.
129. 129 Wallstrom, M., Nilsson, F., Hirsch, J.M., A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction 95:suppl 2 (2000), 1161–1171, 10.1046/j.1360-0443.2000.95811613.x.
130. 130 Ward, K.D., Asfar, T., Al Ali, R., et al. Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. Addiction 108:2 (2013), 394–403, 10.1111/j.1360-0443.2012.04048.x.
131. 131 Wiggers, L.C., Smets, E.M., Oort, F.J., et al. The effect of a minimal intervention strategy in addition to nicotine replacement therapy to support smoking cessation in cardiovascular outpatients: a randomized clinical trial. Eur J Cardiovasc Prev Rehabil 13:6 (2006), 931–937, 10.1097/hjr.0b013e328010f263.
132. 132 Williams, K.E., Reeves, K.R., Billing, C.B. Jr., Pennington, A.M., Gong, J., A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Curr Med Res Opin 23:4 (2007), 793–801, 10.1185/030079907X182185.
133. 133 Wong, J., Abrishami, A., Yang, Y., et al. A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Anesthesiology 117:4 (2012), 755–764, 10.1097/ALN.0b013e3182698b42.
134. 134 Zellweger, J.P., Boelcskei, P.L., Carrozzi, L., Sepper, R., Sweet, R., Hider, A.Z., Bupropion SR vs placebo for smoking cessation in health care professionals. Am J Health Behav 29:3 (2005), 240–249, 10.5993/AJHB.29.3.5.
135. 135 Zernig, G., Wallner, R., Grohs, U., Kriechbaum, N., Kemmler, G., Saria, A., A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation. Addiction 103:12 (2008), 2024–2031, 10.1111/j.1360-0443.2008.02348.x.
136. 136 Hughes, J.R., Stead, L.F., Hartmann-Boyce, J., Cahill, K., Lancaster, T., Antidepressants for smoking cessation. Cochrane Database Syst Rev, 1, 2014, CD000031, 10.1002/14651858.cd000031.pub4.
137. 137 Cahill, K., Stead, L.F., Lancaster, T., Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev, 4, 2012, CD006103, 10.1002/14651858.cd006103.pub6.
138. 138 Stead, L.F., Buitrago, D., Preciado, N., Sanchez, G., Hartmann-Boyce, J., Lancaster, T., Physician advice for smoking cessation. Cochrane Database Syst Rev, 5, 2013, CD000165, 10.1002/14651858.cd000165.pub4.
139. 139 Stead, L.F., Hartmann-Boyce, J., Perera, R., Lancaster, T., Telephone counselling for smoking cessation. Cochrane Database Syst Rev, 8, 2013, CD002850, 10.1002/14651858.cd002850.pub3.
140. 140 Stead, L.F., Lancaster, T., Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev, 2, 2005, CD001007, 10.1002/14651858.cd001007.pub2.
141. 141 Lancaster, T., Stead, L.F., Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev, 2, 2005, CD001292, 10.1002/14651858.cd001292.pub2.
142. 142 Gorber, S.C., Schofield-Hurwitz, S., Hardt, J., Levasseur, G., Tremblay, M., The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res 11:1 (2009), 12–24, 10.1093/ntr/ntn010.
143. 143 Mottillo, S., Filion, K.B., Bélisle, P., et al. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J 30:6 (2009), 718–730, 10.1093/eurheartj/ehn552.